| PERIOD ENDING | 28-Feb-09 | 1-Mar-08 | 3-Mar-07 | | Total Revenue | 26,289,268 | 24,326,846 | 17,507,719 | | Cost of Revenue | 19,253,616 | 17,689,272 | 12,791,597 | | | Gross Profit | 7,035,652 | 6,637,574 | 4,716,122 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 7,025,272 | 6,366,137 | 4,370,481 | | Non Recurring | 2,115,547 | 82,440 | 38,178 | | Others |
-
|
-
| 18,662 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,105,167) | 188,997 | 288,801 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (12,900) |
-
| | Earnings Before Interest And Taxes | (2,105,167) | 176,097 | 288,801 | | Interest Expense | 477,627 | 449,596 | 275,219 | | Income Before Tax | (2,582,794) | (273,499) | 13,582 | | Income Tax Expense | 329,257 | 802,701 | (13,244) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,912,051) | (1,076,200) | 26,826 | | | Non-recurring Events | | Discontinued Operations | (3,369) | (2,790) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (2,915,420) | (1,078,990) | 26,826 | | Preferred Stock And Other Adjustments | (21,870) | (33,191) | (31,557) | | | Net Income Applicable To Common Shares | ($2,937,290) | ($1,112,181) | ($4,731) |
|
0.34% Nasdaq 
Income Statement
